Showing 12,741 - 12,760 results of 113,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.92s Refine Results
  1. 12741

    Primers used in RTqPCR. by Lorenza Cutrone (21144285)

    Published 2025
    “…We detected HSF2 binding to the ORF50 promoter in latent cells, in contrast, in lytic cells, HSF2 occupancy at the ORF50 promoter is lost in conjunction with its proteasomal degradation. …”
  2. 12742
  3. 12743
  4. 12744
  5. 12745
  6. 12746

    Programmed cell death does not cause the thoracoabdominal schisis seen in the FlnA+Fmn2 double null mice. by Gewei Lian (523268)

    Published 2017
    “…<p>Fluorescent photomicrographs show decreased rates of programmed cell death (fluorescein) between WT vs null FlnA, and WT vs null FlnA+Fmn2 cortex within the mouse sternum (WT vs null FlnA ** = p < 0.00012, Wt vs null FlnA+Fmn2 ** = p < 0.0004, null FlnA vs null FlnA+Fmn2 * = p < 0.05). …”
  7. 12747
  8. 12748
  9. 12749
  10. 12750
  11. 12751
  12. 12752
  13. 12753
  14. 12754

    TEMPO-Oxidized Microcrystalline Cellulose for Rapid Adsorption of Ammonium by Jia Hui Ong (12085606)

    Published 2022
    “…The adsorption performance of the material was minimally influenced by a pH range of 5.0–9.0 but substantially affected by the presence of competing ions. …”
  15. 12755
  16. 12756
  17. 12757
  18. 12758
  19. 12759

    A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice by Chunbing Zheng (775311)

    Published 2015
    “…In this study, we explored the therapeutic potential of WB403, a small compound activating TGR5 which was identified by combining TGR5 targeted luciferase assay and active GLP-1 assay, in treating type 2 diabetes. …”
  20. 12760